+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Verified

IASLC Young Investigator Grant

International Association for the Study of Lung Cancer

Program

The IASLC Young Investigator Grants Program funds the training of early-career researchers who wish to pursue careers in lung cancer diagnosis, treatment, or laboratory research as well as other aspects of the study of lung tumors. The committee aims to select one applicant from each of these regions: Asia, Europe, North America, Latin America & Developing Countries (as defined by World Bank), and Australia/Rest of World.

Funding Priorities

Applications must be within the scope of the following funding priorities to be considered: the etiology, epidemiology, prevention, diagnosis, treatment, and all other aspects of lung cancer and thoracic malignancies.

Grant Structure and Allocation

IASLC Young Investigator Grants are in the amount of USD 50,000 and are intended to fund projects that can be completed in a one-year timeframe. The funds are paid in one lump sum directly to the institution for the benefit of the individual who is granted.

Grant funds may be used at the discretion of the recipient for salary, fringe benefits, conference registration, travel, consumables, and other necessary expenses to facilitate his or her research. Funds may not be used for indirect costs, institutional overhead, or the purchase of permanent equipment.

How to Apply

Applications will be accepted through the IASLC's online Research Grant Application Portal only. To access the application:

Go to the IASLC's online Research Grant Application Portal.
Login using your IASLC Member Credentials.
- If you do not know your IASLC Member credentials, first try resetting your password using the "Forgot your password?" link. If that does not work, email membership@iaslc.org for assistance.
Once you have successfully logged in, you will be directed to begin your application.

After initiating an application, the applicant may return to the portal as needed to continue work on their application until it is submitted. Applications that have been submitted remain editable until the application deadline.

AI Based Application Success Predictor

1. Clear Scientific Relevance to Lung Cancer and Thoracic Malignancies

Successful proposals must firmly focus on research questions within the etiology, epidemiology, prevention, diagnosis, treatment, or biology of lung cancer and other thoracic tumors. iaslc.secure-platform.com
Why this matters: Reviewers assess proposals primarily on how they advance understanding or improve care for patients with lung cancer — projects outside this scope are unlikely to be competitive.

2. Alignment with Grant Category and Career Stage

Each IASLC grant targets a well-defined career stage:

Young Investigator: ~0–5 years post-faculty/fellowship. iaslc.secure-platform.com

Gazdar Fellowship: fellows in training. iaslc.secure-platform.com

Career Advancement: mid-career investigators (~6–15 years). iaslc.secure-platform.com

Predictor: Applicants whose experience matches precisely the targeted career level have significantly higher success rates.

3. Scientific Merit, Innovation, and Feasibility

High-scoring proposals generally demonstrate:

Innovative ideas or novel approaches that push lung cancer science forward.

Strong rationale and methodology with clear hypotheses and achievable aims within the project period.

A realistic timeline and defined metrics for success. iaslc.secure-platform.com

Review panels emphasize both significance and approach — projects that are ambitious but feasible typically stand out.

4. Clear Significance and Impact Statements

Well-crafted statements of significance (including lay summaries) that succinctly explain why the research matters — both scientifically and clinically — are strong predictors of success. iaslc.secure-platform.com
Tip: Projects that articulate potential effects on survival, quality of life, or clinical practice often resonate well with both scientific and translational reviewers.

5. Demonstrated Capability of the Applicant

IASLC reviewers look for evidence that the applicant has the skills, track record, and environment to carry out the research:

Previous relevant publications or presentations.

Appropriate academic or clinical background in oncology research.

Support and infrastructure at the host institution.

Even early-career awards consider the investigator’s promise and preparedness.

6. Global Representation and Diversity

For programs like the Young Investigator Grant, IASLC selects recipients from multiple world regions (e.g., Asia, Europe, North America, Latin America & Developing Countries). iaslc.secure-platform.com
Predictor: Applicants who demonstrate significance for their region — especially emerging regions — may have competitive advantages in these geographically stratified awards.

7. Membership and Engagement with the IASLC Community

Being an active IASLC member is required and beneficial:

IASLC membership is mandatory for grant eligibility. iaslc.secure-platform.com

Engagement (e.g., presenting abstracts at IASLC meetings, participating in working groups) can raise visibility and familiarity with the research community.

🧠 Patterns Seen Among Successful Applicants

Analysis of recent awardees shows that funded researchers typically:

Tackle cutting-edge questions in lung cancer biology, diagnostics, or therapy. IASLC

Represent a range of institutions globally — from major academic cancer centers to emerging research environments. IASLC

For translational or larger grants, design studies with clear steps toward clinical impact. IASLC

📌 Practical Tips to Boost Competitiveness

✔ Match your research topic clearly to lung cancer priorities outlined by the IASLC.
✔ Follow the specific grant’s instructions thoroughly, including eligibility and application content.
✔ Craft compelling lay and scientific summaries that convey impact and feasibility.
✔ Build a robust methods and timetable section showing how you will achieve aims within the award period.
✔ Demonstrate institutional support, such as access to relevant samples, clinical cohorts, or lab infrastructure.

📊 Summary of Success Predictors

Predictor	Why It Matters
Topic relevance to lung cancer	Core mission of IASLC funding
Appropriate career stage fit	Grants are stratified by career level
Innovativeness & feasibility	High scientific merit and achievability
Clear significance & impact	Demonstrates value to the field
Investigators’ capability	Signals likelihood of success
Geographic diversity (for regional awards)	Encourages global representation
IASLC membership & engagement	Eligibility AND community integration

Specialties

Cancer

Pulmonology

Oncology

Eligibility Requirements

IASLC Young Investigator Grants are open to candidates worldwide. At the time of application, the applicant must meet all these requirements:

The applicant (MD, DO, PhD, PharmD, or equivalent) must be within five years of initial faculty appointment.
The applicant must be a member of the IASLC, and if selected for grant funding, must maintain IASLC membership for the duration of the grant. If you are not a member, please click here to join.
Postdoctoral researchers from non-profit institutions (including academic and governmental institutions) are eligible to apply. Researchers from for-profit institutions will not be considered.

Sponsor Details

Sponsor Institute/Organizations: International Association for the Study of Lung Cancer

Sponsor Type: Corporate/Non-Profit

Address: 1775 N. Sherman Street, Suite 1600, Denver, CO 80203-4317

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity